孙显松;侯晓荣;刘晓明;周兵;柴爽;胡克;邱杰;张福泉;
SUN Xian-song;HOU Xiao-rong;LIU Xiao-ming;ZHOU Bing;CHAI Shuang;HU Ke;QIU Jie;ZHANG Fu-quan;Department of Radiation Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院放疗科

摘要(Abstract)：

新型冠状病毒肺炎疫情属于突发公共卫生事件,严重威胁人类健康,肿瘤患者是新型冠状病毒感染的高危人群。放疗作为肿瘤治疗的重要手段之一,在疫情期间成为重要的替代或延缓手术的治疗手段。北京协和医院放疗科在疫情防控期间通过制定严密而科学的防控管理体系,保证了放疗工作的顺利开展。本文对防控管理相关策略进行总结与思考,为突发公共卫生事件期间开展放疗工作提供经验参考。
Coronavirus disease 2019(COVID-19),as a public health emergency, is a serious threat to human health. Cancer patients have a high risk of being infected with COVID-19. As one of important means of cancer treatment, radiotherapy has become an important alternative to surgery during the epidemic of COVID-19. The radiotherapy department of Peking Union Medical College Hospital ensured the smooth development of radiotherapy work on the setup of prevention and control systems for COVID-19 by establishing admission strategies for cancer patients, disinfection, isolation, daily management measures, scientific exploration,and clinical practice. In this paper, the associated strategies are summarized and analyzed, which can provide experience and reference for radiotherapy treatment under public health emergencies.

关键词(KeyWords)： 新型冠状病毒肺炎;放射治疗;流行病;感染控制
coronavirus disease 2019;radiotherapy;epidemic;infection control

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 孙显松;侯晓荣;刘晓明;周兵;柴爽;胡克;邱杰;张福泉;
SUN Xian-song;HOU Xiao-rong;LIU Xiao-ming;ZHOU Bing;CHAI Shuang;HU Ke;QIU Jie;ZHANG Fu-quan;Department of Radiation Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

Email:

DOI:

参考文献(References)：

• [1] Siavashpour Z,Taghizadeh-Hesary F,Rakhsha A.Recommendations on Management of Locally Advanced Rectal Cancer During the COVID- 19 Pandemic:an Iranian Consensus[J].J Gastrointest Cancer,2020,51:800- 804.
• [2] Dai M,Liu D,Liu M,et al.Patients with Cancer Appear More Vulnerable to SARS-CoV-2:A Multicenter Study during the COVID- 19 Outbreak[J].Cancer Discov,2020,10:783- 791.
• [3] Forner D,Noel CW,Wu V,et al.Nonsurgical manage-ment of resectable oral cavity cancer in the wake of COVID- 19:A rapid review and meta-analysis[J].Oral Oncol,2020,109:104849.
• [4] Combs SE,Belka C,Niyazi M,et al.First statement on preparation for the COVID- 19 pandemic in large German Speaking University-based radiation oncology departments[J].Radiat Oncol,2020,15:74.
• [5] Vordermark D.Shift in indications for radiotherapy during the COVID- 19 pandemic?A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups[J].Radiat Oncol,2020,15:140.
• [6] Vecchione L,Stintzing S,Pentheroudakis G,et al.ESMO managementand treatment adapted recommendations in COVID- 19 era:colorectal cancer[J].ESMO Open,2020,5:e000826.
• [7] Thomas K,Martin T,Gao A,et al.Interruptions of head and neck radiotherapy across insured and indigent patientpopulations[J].J Oncol Pract,2017,13:e319-e328.
• [8] Wu Y,Guo C,Tang L,et al.Prolonged presence of SARS-CoV- 2 viral RNA in faecal samples[J].Lancet Gastroenterol Hepatol,2020,5:434- 435.
• [9] Castelnuovo P,Turri-Zanoni M,Karligkiotis A,et al.Skull Base Surgery During the COVID- 19 Pandemic:The Italian Skull Base Society Recommendations[J].Int Forum Allergy Rhinol,2020,10:963- 967.
• [10] Abramowicz JS,Basseal JM,Brezinka C,et al.ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV- 2 for practitioners undertaking obstetric and gynecolo-gical ultrasound[J].Ultrasound Obstet Gynecol,2020,55:886- 891.
• [11] Obek C,Doganca T,Argun OB,et al.Management of prostate cancer patients during COVID- 19 pandemic[J].Prostate Cancer Prostatic Dis,2020,23:398- 406.
• [12] Jones CM,Radhakrishna G,Aitken K,et al.Considera-tions for the treatment of pancreatic cancer during the COVID- 19 pandemic:the UK consensus position[J].Br J Cancer,2020,123:709- 713.